OSG · Octave Specialty Group, Inc.

The First Amendment represents a significant expansion of Octave Specialty Group’s indebtedness, increasing total term loan exposure by nearly 40% — from $99,375,000 to $139,375,000 — with no stated change to maturity or pricing terms. This financing was not for organic growth or acquisition but to satisfy a contractual put obligation owed by Cirrata UK to minority shareholders of Octave Specialty Limited, indicating contingent liability crystallization within the UK-based subsidiary structure. The pledge of Everspan Holdings, LLC equity introduces a new layer of collateralization, potentially constraining future strategic flexibility around that entity. The involvement of eight distinct legal entities across three jurisdictions as Borrowers underscores the complexity of the group’s capital structure and intercompany arrangements. While the amendment preserves consistency in loan terms, the size of the incremental borrowing — over 28% of total term debt — signals elevated near-term liquidity pressure tied to minority shareholder exit mechanisms, which may recur if similar put rights exist elsewhere in the group. Investors should monitor covenant compliance, especially given the expanded leverage and newly encumbered asset, and assess whether this event reflects broader capital allocation stress within the specialty finance platform.